TransDigm director Howley unloads shares worth over $7.5 million

TransDigm Group INC (NYSE:TDG) director W. Nicholas Howley has sold shares in the company valued at over $7.5 million, according to a recent SEC filing. The transactions, which took place on September 16, involved the sale of shares at prices ranging from $1,366.87 to $1,385.64.


The SEC filing revealed that Howley sold a total of 5,172 shares of common stock, which at the lowest selling price of $1,366.87 per share, would amount to approximately $7,071,671.24. At the highest price of $1,385.64 per share, the total value of the shares sold would be $7,167,910.88. This range indicates a significant cash-out for the director, though the exact details of each transaction's value were not disclosed in the filing.


In addition to the sales, Howley also reported acquiring the same number of shares through the exercise of options, with each option having an exercise price of $215.92. The total value for these "M" transactions was reported at $1,181,514.


The nature of the ownership for these transactions has been indicated as indirect, with the shares being held in the W. Nicholas Howley Family Trust dated April 23, 1999.


Investors often monitor insider transactions such as these for insights into the perspectives of high-level executives and directors within the company. However, it's important to note that these transactions do not necessarily indicate a change in company fundamentals or future performance.


TransDigm Group INC, with its headquarters in Cleveland, Ohio, specializes in the manufacturing of aircraft parts and auxiliary equipment. The company has been a key player in the aerospace industry, and insider transactions are closely followed by market participants.


The filing also included footnotes specifying that the reported prices for the sales were average weighted prices, with the actual sales occurring at various prices within the provided ranges. The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price upon request.


The reported transactions were signed off by Gabrielle Feuer as attorney-in-fact on September 18, 2024.



In other recent news, TransDigm Group Incorporated has reported a robust third quarter performance, leading to increased revenue and a raised fiscal year outlook. The company's margins reached a record high of 53.3%, supported by a strong 15% organic growth. TransDigm has also announced plans for a $3 billion debt offering, the proceeds of which, along with available cash, are intended to fund a special cash dividend to stockholders estimated between $3.5 billion and $4.5 billion.


JPMorgan has updated its stance on TransDigm, raising the company's price target to $1,435.00 from $1,350.00, while maintaining a Neutral rating. This adjustment follows a comprehensive review of the company's recent earnings report and the inclusion of new acquisitions SEI and Raptor into JPMorgan's estimates for TransDigm.


KeyBanc has maintained an Overweight rating on TransDigm, and Jefferies has retained a Buy rating, despite reducing their price target to $1,515 from $1,625. Both firms recognized the company's strong performance in its third fiscal quarter.


TransDigm's recent acquisitions have contributed to a positive outlook, with expectations of high teens percentage growth in defense market revenue and around 20% for commercial OEM. These are recent developments that investors should take note of.
InvestingPro Insights


As TransDigm Group INC (NYSE:TDG) director W. Nicholas Howley's recent share transactions draw attention, investors may also consider the latest financial metrics and analyst insights from InvestingPro to gauge the company's current market position and future outlook. TransDigm's strong financial performance is reflected in its impressive gross profit margin of 59.31% over the last twelve months as of Q3 2024, showcasing the company's efficiency in managing its cost of goods sold relative to its revenue which stood at $7.606 billion USD in the same period.


However, investors should be aware of certain cautionary signals. According to InvestingPro Tips, analysts have revised their earnings expectations downwards for the upcoming period, suggesting potential headwinds or a conservative outlook for the company's near-term performance. Additionally, TransDigm is trading at a high earnings multiple, with a P/E ratio of 51.32, indicating that the company's stock might be valued richly in the market relative to its earnings.


For those looking to delve deeper into TransDigm's financial health and performance, InvestingPro offers a comprehensive list of additional tips. Currently, there are 13 more InvestingPro Tips available for TransDigm, which can provide investors with a more nuanced understanding of the company's valuation, profitability, debt levels, and historical returns. Interested readers can explore these insights by visiting the dedicated page for TransDigm on InvestingPro.


Lastly, it's noteworthy that despite the insider sale, TransDigm has shown a strong return over the last year, with a 63.89% price total return as of the latest data, suggesting that the market has responded favorably to the company's overall performance and strategic initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Останні публікації
Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps
20.09.2024 - 18:00
RBC says this stock is a 'top mid-cap cybersecurity idea,' starts coverage at Buy
20.09.2024 - 18:00
Ryman Hospitality Properties director sells $96,588 in company stock
20.09.2024 - 18:00
Trump Media shares drop after lock-up expires
20.09.2024 - 18:00
ECB Bancorp CFO acquires $69.9k in company stock
20.09.2024 - 18:00
Earnings call: Alliance Entertainment announces mixed FY 2024 results
20.09.2024 - 18:00
Fed's relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports
20.09.2024 - 18:00
Nike veteran Hill to replace Donahoe as CEO; shares jump  
20.09.2024 - 18:00
Novo Nordisk shares drop more than 4% on disappointing obesity pill data
20.09.2024 - 18:00
Johnson Controls EVP and CFO sells $13.7k in stock
20.09.2024 - 18:00
'Temu Threat Abating in 2Q24' - Barclays
20.09.2024 - 18:00
Here's why BTIG says they would be "patient buyers" after large Fed rate cut
20.09.2024 - 18:00
US FDA approves Zevra's treatment for rare genetic disease
20.09.2024 - 18:00
Premier Inc. CFO Craig McKasson sells $204,100 worth of shares
20.09.2024 - 18:00
Earnings call: iPower reports mixed results, optimistic about 2025
20.09.2024 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз трейдера Аналіз трейдера за 20.09.24
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.